Sipuleucel-T (Sip-T) in Combination With N-803 in Metastatic Androgen Pathway Modulation Resistant (mAPMR) Prostate Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Metastatic Prostate Cancer
Related studies linked through entity extraction aliases.
[18F]Fluorthanatrace - Positron Emission Tomography (FTT-PET) and ctDNA to Predict Response to PARP Inhibitor Therapy in Metastatic Prostate Cancer (mPC)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
PSMA PET-Guided Progression-Directed Radiotherapy for Oligoprogressive Prostate Cancer
- Status
- RECRUITING
- Phase
- N/A
Prostate Radiotherapy and Metastasis-Directed Therapy in Synchronous Oligometastatic Prostate Cancer
- Status
- RECRUITING
- Phase
- N/A
Response With Interim PSMA PET in Metastatic Castration-sensitive Prostate Cancer for Optimization of Adaptive Metastasis-directed Radiotherapy Delivery
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1
Study of PSMA-targeted Therapy and Androgen Receptor Suppression in Low-volume Metastatic ProstatE Cancer: SPARKLE Trial
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
First-in-human Diagnostic Imaging Profile of the Theranostic Pair [68Ga]Ga-DOTA-STR-17126 and Low Dose [177Lu] Lu-DOTA-STR-17126 in Patients With Advanced or Metastatic Cancer
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Clinically Actionable Tumor-Associated Antigens in Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Prostate Specific Membrane Antigen (PSMA) Imaging for Detection of Residual and Metastatic Prostate Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
PROMET-BR - Molecular Profiling of Metastatic Prostate Cancer: a Brazilian Cohort
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
First-in-Human Study to Evaluate AZD8359 STEAP2 TCE in Participants With Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
PULSE Registry: for Patients Receiving Lutetium (177Lu) Vipivotide Tetraxetan
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
ACTinium in Castrate-RESistant Prostate Cancer After LUTEtium
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Pharmaceutical Management in Targeted Radioligand Therapy
- Status
- RECRUITING
- Phase
- N/A
Exploiting Heterogeneity in Hormone Therapy Response to Reveal Early Determinants of Drug Resistance in Advanced PCa
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Dapagliflozin Combined With Next-generation Hormonal Agent (NHA) Versus Single NHA in Participants With Metastatic Castrate-resistant Prostate Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Real-world Use of Lutetium (177Lu) Vipivotide Tetraxetan in China(PSMAreal CN)
- Status
- RECRUITING
- Phase
- N/A
CONVERT-HB1: Radical Prostatectomy After Systemic Therapy for High-volume Metastatic Hormone-sensitive Prostate Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2